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1. INTRODUCTION 
Treatment of cells with galactose oxidase fol- 
lowed by reduction with radioactive sodium-boro- 
tritide (NaBI$) is widely employed for the analy- 
sis of cell surface glycoconjugates [l-3]. We have 
used galactose oxidase in conjunction with lectins 
specific for D-galactose and N-acetyl-D-galac- 
tosamine, to investigate the organization of glyco- 
conjugates on human erythrocytes. In the course of 
these studies we have observed that erythrocytes 
from differeui individuals differ markedly in their 
sensitivity to the enzyme, as assessed by the de- 
crease in agglutinability by, and binding of, soy- 
bean agglutinin (SBA). In particular, erythrocytes 
from certain individuals of blood type A or AB 
were only slightly affected by the enzyme. Since 
the receptors for SBA on human erythrocytes are 
primarily glycolipids [4,5], our data strongly sug- 
gest that here are considerable differences in the 
susceptibility of these glycolipids to galactose ox- 
idase and that such differences are genetically de- 
termined. 
the cold and used within 7-10 days. Erythrocytes 
were washed 3-4 times with phosphate-buffered 
saline (0.05 M phosphate, 0.15 M NaCl (pH 7.4) 
(PBS) before use. Erythrocyte ghosts were pre- 
pared by osmotic shock in 5 mM sodium-phos- 
phate buffer (pH 8) [16], containing 0.1 M PMSF. 
They were dissolved in PBS containing 1% Triton 
X-100, 1% ethanol and 0.1 mM PMSF with 5- 
10 min sonication in a water bath. 
SBA was purified by affinity chromatography 
[7]; it was iodinated by the chloramine T method 
in [S] and repurified by affinity chromatography. 
The product had 50 000-60 000 cpm/pg. Binding 
of [125I]SBA to erythrocytes (5 x lo7 cells) was 
performed as described for lymphocytes [9] except 
that separation of the labeled cells from excess lec- 
tin was by centrifugation on a 2: 1 (instead of 1: 1) 
mixture of dioctylphthalate:dibutylphthalate. 
2. MATERIALS AND METHODS 
Hemagglutination tests were done by the double 
dilution technique in microtiter plates [lo]. Poly- 
acrylamide gel electrophoresis in sodium dodecyl- 
sulfate (SDS) was done in 8% running gels with the 
discontinuous buffer system in [ll]. [t25I]SBA 
binding in situ was done on unstained gels by the 
overlay technique in [ 121. 
Freshly-drawn blood obtained from healthy 
consenting donors was collected in citrate-glucose 
anticoagulant; phenylmethylsulfonyl fluoride 
(PMSF) was then added to 0.1 mM final cont. and 
the blood was either used immediately or stored in 
Protein was determined according to [13] with 
the Dye Reagent from Bio-Rad Labs., using 
bovine serum albumin as standard. 
Abbreviations: PBS, phosphate buffered saline (pH 7.4); 
PMSF, phenylmethylsulfonyl fluoride; SBA, soybean 
agglutinin; SDS, sodium dodecylsulfate 
Treatment with galactose oxidase was done on 
20% suspensions of erythrocytes in PBS with vary- 
ing amounts of the enzyme in the presence of 10 
units/ml of catalase. After 1 h at 37°C the cells 
were washed sequentially with PBS, PBS contain- 
ing 0.1 M D-galactose and 3 times with PBS (5-10 
vol. each wash). The cells were used immediately 
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for agglutination or binding experiments. 
Trypsinization of erythrocytes was carried out 
with 1OOpg enzyme/ml of a 10% suspension of 
cells in PBS for 1 h at 37°C. 
Carrier-free Nat*51 was from Radiochemical 
Center (Amersham). Trypsin (2 X crystallized) 
and galactose oxidase (50-125 units/mg) were 
from Sigma. To inactivate proteolytic contami- 
nants that may be present in the latter enzyme, it 
was heated at 225 units/ml PBS for 30 min at 56°C 
before use. In the early experiments, galactose ox- 
idase was from Kabi (Stockholm) as specified in 
the results. This enzyme was protease free and did 
not require any pretreatment. Catalase was from 
Worthington. 
3. RESULTS AND DISCUSSION 
Human erythrocytes readily undergo agglutina- 
tion by SBA, with 8-16 pg/ml of the lectin giving 
complete agglutination in a serial dilution assay in 
microtiter plates. Upon treatment with galactose 
oxidase, we found that the cells from most individ- 
uals became much less susceptible to agglutination 
by the lectin (up to 16-32-fold at 20 units/ml of 
enzyme) (fig.1, A-C). We have designated such 
cells as ‘sensitive’. Occasionally there were, how- 
ever, donors whose erythrocytes responded poorly 
to oxidation by the enzyme, showing a decrease of 
2-4-fold in agglutinability (tig.1, rows E-G); such 
cells were designated as ‘resistant’. A considerable 
proportion of donors had cells with intermediate 
degrees of sensitivity. In all cases, the susceptibility 
to agglutination by SBA of the oxidized cells was 
completely restored to that of untreated cells by 
reduction with NaBH4 (1 mg/ml, 30 min at room 
temperature) (fig. 1, rows D, H). Such high concen- 
trations of NaBH4 had to be used since we noted 
that at lower concentrations the effect of galactose 
oxidase on the interaction of cells with SBA was 
A 
B 
C 
D 
Fig.1. 
A-D 
37°C; 
Effect of galactose oxidase on the agglutination of erythrocytes from two donors of blood type A. Cells in rows 
from donor 1, D-H from donor 2: (A,E) untreated; (B,F) incubated with 2 units of galactose oxidase for 1 h at 
(C,G) same with 20 units of enzyme: (D.H) cells treated as in (C) and (G), respectively. then reduced with 
NaBH4. 
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Fig.2. Distribution of cells sensitive and resistant to 
galactose oxidase amongst donors of different ABO 
blood types. The number on the ordinate gives the de- 
crease in SBA agglutination titer upon treatment of the 
cells with 20 units of galactose oxidase. 
only partially reversed. The need for high concen- 
trations of NaBfi for the complete reduction of 
oxidized D-galactose and N-acetyl-D-galactos- 
amine residues on erythrocytes was also reported 
in [14]. 
A survey uf erythrocytes from 132 donors re- 
vealed that 16% had resistant cells (fig.2); all of 
these were individuals of blood type A or AB, 
comprising -35% of this population. Sensitive 
cells, on the other hand, were found in all blood 
types. Sensitivity was most pronounced among cer- 
tain individuals belonging to blood groups 0 and 
B, where cases were found with a 64-fold decrease 
in agglutinability upon treatment with galactose 
oxidase. No correlation with blood types At, AZ, 
Rh and P was observed. The degree of sensitivity 
of cells from an individual donor remained con- 
stant when fresh samples of blood were taken over 
a period of months up to 2 years. No difference 
was found in the effect of galactose oxidase on the 
agglutinability of sensitive and resistant cells by 
other D-galactose or N-acetyl-D-galactosamine 
specific lectins (from Erythrina cristagalli, Ricinus 
communis, Tridacna maxima and Crotolaria 
juncea). This may be because binding of these lec- 
tins is not affected by oxidation at C-6 of D-galac- 
tose/N-acetyl-D-galactosamine or because they 
bind to sites different from those to which SBA 
binds. 
treated with galactose oxidase was accompanied 
by a decrease in binding of the lectin and was 
much more pronounced with sensitive than resis- 
tant cells (fig.3). Similar results were obtained with 
galactose oxidase from 2 sources (Sigma, used rou- 
tinely, and Kabi, the production of which was dis- 
continued some time ago). Binding (> 95%) was 
restored by reduction of the oxidized cells with 
1 mg NaB&/ml. Both sensitive and resistant un- 
treated erythrocytes gave overlapping binding 
curves in the range tested (lo- 160 pg SBA/ml; not 
shown), strongly suggesting that the number of 
SBA binding sites is identical. 
Treatment of resistant and sensitive cells with 
trypsin prior to oxidation with galactose oxidase 
resulted in a IO-fold increase in their agglutin- 
ability and only a slight increase (< 20%) in the 
total amount of SBA bound to both cell types, but 
did not change the relative sensitivity of the cells to 
the enzyme (not shown). 
The molecular nature of the SBA receptor on 
human erythrocytes has not been unequivocally 
established. In [4,5] lectin was found to bind pri- 
marily to the glycolipids of the membrane. These 
findings have now been confirmed by staining of 
gels with [ t*5I]SBA. Both with sensitive and resis- 
tant erythrocytes, the lectin binds almost ex- 
clusively at the glycolipid region (tig.4). 
The decrease in agglutinability of SBA cells Our data suggest that there are genetically con- 
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Fig.3. Effect of galactose oxidase on binding of human 
erythrocytes. Cells of type AB (filled symbols) or type A 
(empty symbols) were treated with varying amounts of 
galactose oxidase from Kabi or Sigma, respectively: 
(*,o) resistant cells; (A,A) sensitive cells. Binding after 
reduction with NaBH4 is given only for type AB cells. 
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Fig.4. Autoradiograms of SDS-polyacrylamide gels of 
ghosts of sensitive and resistant cells stained with 
[1251]SBA: (a) sensitive cells; (b) resistant cells. 
trolled variations in the sensitivity to galactose ox- 
idase of at least some of the erythrocyte glycolipids 
of different individuals. Such variations may be 
due to differences in composition and structure of 
membrane glycolipids, or due to their relative dis- 
position in the membrane. The structure of the 
lipid aglycon in galactolipids [ 151 and the pattern 
of substitution of the penultimate sugar residue in 
galactosyl di- and trisaccharides [16] markedly af- 
fected their susceptibility to galactose oxidase. The 
October 1982 
ceramide composition may also define the orienta- 
tion of the carbohydrate chain of a glycolipid in 
the membrane, thus affecting its accessibility to ex- 
ternal agents [ 171. 
One obvious candidate for the SBA receptor is 
globoside, since it possesses a terminal non-reduc- 
ing N-acetyl-D-galactosamine residue for which 
SBA is highly specific, and is the major glycolipid 
of the human erythrocyte membrane (65% of total), 
corresponding to - 107 copies/cell, which is more 
than sufficient for the number of SBA binding 
sites per cell (1.2 x 106) [ 181. This is also the major 
glycolipid substrate for galactose oxidase in the 
erythrocyte membrane and is more exposed on the 
cell surface than any other erythrocyte membrane 
glycolipid [ 1,2]. Moreover, preliminary experi- 
ments using the overlay method [19] with thin- 
layer chromatograms of lipid extracts of the eryth- 
rocyte membrane have demonstrated that the 
lectin does, indeed, bind to globoside, although 
binding to trihexosylceramide was also observed. 
Binding of SBA to the above glycolipids, primary 
to globoside, as well as to GM2, has also been re- 
ported in a study on the interaction of the lectin 
with glycolipid components of porcine lymphocyte 
plasma membranes (201. Work on the identifica- 
tion of the glycolipid receptor(s) of SBA in the 
erythrocyte membrane which is differentially af- 
fected by galactose oxidase is in progress in our 
laboratory. 
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